Neurobiology of Alcohol Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Neuropsychopharmacology. 2018 Mar;43(4):838-850. doi: 10.1038/npp.2017.120. Epub 2017 Jun 7.
κ-Opioid receptors (KORs) and their endogenous ligand dynorphin are involved in stress-induced alcohol seeking but the mechanisms involved are largely unknown. We previously showed that systemic injections of the KOR agonist U50,488, which induce stress-like aversive states, reinstate alcohol seeking after extinction of the alcohol-reinforced responding. Here, we used the neuronal activity marker Fos and site-specific injections of the KOR antagonist nor-BNI and U50,488 to study brain mechanisms of U50,488-induced reinstatement of alcohol seeking. We trained male Long-Evans rats to self-administer alcohol (12% w/v) for 23-30 days. After extinction of the alcohol-reinforced responding, we tested the effect of U50,488 (0, 1.25, 2.5, and 5 mg/kg) on reinstatement of alcohol seeking. Next, we correlated regional Fos expression with reinstatement induced by the most effective U50,488 dose (5 mg/kg). Based on the correlational Fos results, we determined the effect of bed nucleus of the stria terminalis (BNST) injections of nor-BNI (4 μg/side) on U50,488-induced reinstatement of alcohol seeking, and reinstatement induced by injections of U50,488 (0, 0.3, 1, and 3 μg/side) into the BNST. U50,488-induced reinstatement of alcohol seeking was associated with increased Fos expression in multiple brain areas, including the BNST, where it was significantly correlated with lever pressing. U50,488-induced reinstatement was blocked by BNST nor-BNI injections, and BNST U50,488 injections partially mimicked the drug's systemic effect on reinstatement. Our data indicate that the BNST is a critical site for U50,488-induced reinstatement of alcohol seeking and suggest that KOR/dynorphin mechanisms in this brain area play a key role in stress-induced alcohol seeking.
κ-阿片受体(KORs)及其内源性配体强啡肽参与应激诱导的酒精觅药,但涉及的机制在很大程度上尚不清楚。我们之前的研究表明,全身注射 KOR 激动剂 U50,488 会诱导出类似于应激的厌恶状态,从而在酒精强化反应的消退后重新引发酒精觅药。在这里,我们使用神经元活动标记物 Fos 和 KOR 拮抗剂 nor-BNI 和 U50,488 的特异性注射,研究 U50,488 诱导的酒精觅药复吸的脑机制。我们训练雄性长耳大白鼠进行 23-30 天的酒精(12% w/v)自我给药。在酒精强化反应的消退后,我们测试了 U50,488(0、1.25、2.5 和 5mg/kg)对酒精觅药复吸的影响。接下来,我们将区域 Fos 表达与最有效 U50,488 剂量(5mg/kg)诱导的复吸相关联。基于相关的 Fos 结果,我们确定了终纹床核(BNST)中 nor-BNI(4μg/侧)注射对 U50,488 诱导的酒精觅药复吸的影响,以及 BNST 中 U50,488(0、0.3、1 和 3μg/侧)注射诱导的复吸。U50,488 诱导的酒精觅药复吸与包括 BNST 在内的多个脑区 Fos 表达的增加有关,在 BNST 中,它与压杆的相关性非常显著。BNST 中 nor-BNI 的注射阻断了 U50,488 诱导的觅药复吸,而 BNST 中 U50,488 的注射部分模拟了该药物对复吸的全身作用。我们的数据表明 BNST 是 U50,488 诱导的酒精觅药复吸的关键部位,并表明该脑区的 KOR/强啡肽机制在应激诱导的酒精觅药中起着关键作用。